Abstract Library

Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.

Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.

 

Please note:

Participants of the 2025 ENETS Conference enjoy full access to the 2025 conference digital resources through myENETS: the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more.

Log in to myENETS

ENETS Abstract Search

#1457 Small and Large Incidental Non-Hyperfunctiong Pancreatic Neuroendocrine Tumors: Spectrum of Magnetic Resonance Imaging Features

Introduction: The improvement of imaging techniques significantly increased the detection of small incidental non-hyperfunctioning pancreatic neuroendocrine neoplasms (NF-PanNENs). Most NF-PanNENs

Conference: 13th Annual ENETSConcerence (2016)

Presenting Author:

Authors: De Robertis R, D'Onofrio M, Butturini G, Tinazzi Martini P, Paiella S,

Keywords: Pancreas, neuroendocrine neoplasms, magnetic resonance imaging,

#1226 Follow Up of ≤ 2 cm Non Functioning Pancreatic NETs in Patients with MEN1 Treated with Conservative Approach

Introduction: There is a current trend for conservative treatment of non functioning pancreatic NET (NF-PNETs), ≤ 2 cm, in patients with MEN1, which are reported to be associated with low risk of metastasis and death.

Conference: 12th Annual ENETSConcerence (2015)

Presenting Author: Davi' M

Authors: Davì M, Cosaro E, Malpaga A, Butturini G, Ortolani S,

Keywords: Pancreatic neuroendocrine tumor, MEN1,

#1198 Role of Combined 68Ga-DOTATOC and 18F-FDG PET-CT in the Diagnostic Workup of Well Differentiated Pancreas Neuroendocrine Tumors (PanNETs): A Surgical Series

Introduction: PanNETs have a broad spectrum of aggressiveness. Somatostatin-receptor based functional imaging, [68Ga]DOTATOC-PET/CT (GP), is recommended in the diagnostic workup of PanNETs; preliminary evidences show that [18F]FDG-PET/CT (FP) can provide prognostic information.

Conference: 12th Annual ENETSConcerence (2015)

Presenting Author:

Authors: Ortolani S, Butturini G, Malpaga A, Cingarlini S, Malfatti V,

Keywords: pancreas neuroendocrine tumor, PET, tumor grade,

#858 Metastatic Pancreatic Neuroendocrine Tumors with Ectopic Cushing Syndrome: Could Everolimus Be a Safe Therapeutic Option?

Introduction: Everolimus(E) has proved effective in prolonging PFS in advanced P-NETs. As E is a substrate of CYP3A4 co-administration with ketoconazole (k), a strong inhibitor of CYP3A4 used to control hypercortisolism, should be avoided.

Conference: 11th Annual ENETSConcerence (2014)

Presenting Author: davi' m

Authors: Davì M, Cingarlini S, Butturini G, Capelli P, Scarpa A,

Keywords: Everolimus, pancreatic NET, ectopic Cushing syndrome,